P47716 AF NFT

DNA-directed RNA polymerase subunit beta'

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigbpu7eqv3grwvecpvw5e43z527fmza6nqz7o42ffh5nyba3gaqou/metadata.json
IPFS of structure file: 
bafybeibfc4pyk3oeia4d5t4idq5lubgx242c2lrzg5uwzbzxeoysmd7kby/AF-P47716-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x10d32b192C4f99E6DAa9fBCb71097F3EdA1D0CAC
First NFT owner address (bech32): 
genesis1zrfjkxfvf7v7dk4fl09hzztl8mdp6r9vd6ufn7
Current NFT ID #388495 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388495
Accession (UniProt):
P47716
Name::
DNA-directed RNA polymerase subunit beta'
Experimental Method:
Predicted structure
Sequence source:
Mycoplasma gallisepticum (strain R(low / passage 15 / clone 2))

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P47716 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P47716|RPOC_MYCGA DNA-directed RNA polymerase subunit beta' OS=Mycoplasma gallisepticum (strain R(low / passage 15 / clone 2)) OX=710127 GN=rpoC PE=3 SV=2 MDKLNKKNKNKRIRGLQISIASAEEMRSWSHGEVKKPETINYKSLKPETDGLFDEAIFGPVKDFECACGKYKKIKHRGRTCEKCGVEITESIVRRERMGHIDLAVPVAHIWMTKELPSPSKISLVLDVSYKEVEEVVYFVNYIILNPGNSKNPVFKFKEVVDLSGKGSKSARIKLRKVLREIKDKHQADKHSIIYKRASDYYNKLKESHLPFSIDEVAKFIETHTGIRLGIGAEAILELLEGVDLQKEYDLINEELNSYSKDLKANKEDQKVKRALRRLETIKWLKESGIKASNMILKVIPVTPPDTRPIIQLDGARFTTSDINNFYRRIIIRNERLKKIIELRAPSVILNNEKRMLQEVVDALFDNASRKKPITAKDKRPLKSLTDRLKGKQGLFRQNLLGKRVDYSGRSVIVIGPELKMYEVGIPAPMILKLFKPFIIRELIMRFNEDGQEIKPIAPNIKIAEQMIAQKSERIWDIVDKVIKERPVLLNRAPTLHRLGIQAFEPKIVDGKAIRLHPLVTTAFNADFDGDQMAVHVPISKEAVAEARAIMLASWHILGPKDGKPVATPTQDMVLGNYYLTTEKRNEKGEGLIFSDFDQVILAYEAKQVSIHALIGLSTKCLTKKPFAKQGIVITTVGKAIMNSIMPEEMAYLNDGDNLLELDESNIVFAGEDFKQKLAKRPLYKPFGKKTLSKIIEILYKNFPLQKVPQVLDKIKEFGFKYSTLSSTTISVFDIPRYDNKQEYITKANEMIAKLKHMYQKGLLTDDERYTKVIRLWADVKDNVSRDIKEIITRPEYKENSIVVIADSGARGNISNFTQLFGMRGLMSKSYNYDQKIKSQVIRDTIEVPIKHSFIEGLTINEYFNSSYGARKGMTDIAMKTSKSGYMTRKLVDAAQEVIINDSDCNTNKGIVVSTITNSLDGGVVETLSERIVTRYTIDPIYDEKTKELLVDADTLITSELAEKIAKANVTKALIRSPIYCQSTKGLCQKCFGNDLTTNDLVQIGTAIGVIAAQSIGEPGTQLTMRTFHTGGTANEGNITQGFERLKQIFDVVSPKEWELATIAENEGVVESITSDATARIIRIKTRLEAEEYRVPFDAVISVNPKDVVYPGSKLTEGSIDIKHLLRVAGIETVRQYFLEEVQKVYRLQGIEIADKYVEVTIRQLTNKLQVIDVGDSDYFVGQTVDINKFRKEVTNMLIANKRPPVAINQVFGLDEAPAKTGSFLSAASFQDTKKILTDAAVKNQIDYLVGLKENVILGNLIPAGTGFMSSEEIIKAGEEALEKEY